Insight Holdings Group, LLC sold $51.6M of HNGE (indirect holdings)

Insight Holdings Group, LLC sold 727,793 indirectly-held shares of Hinge Health, Inc. (HNGE) at an average of $70.95 ($70.21–$71.67, $51.63M total) across 18 trades over 2026-06-22 to 2026-06-24 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Insight Holdings Group, LLC
Published Jun 25, 2026, 1:56 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 25, 2026, 2:05 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$HNGE
Neutral
medium confidence
Mentioned
$HNGE
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HNGENeutralLow
01

Why it matters

The newest actionable element is the disclosed sale size (~$51.6M) and the fact it fully reduced holdings to 0 shares after the transaction window.

02

Market read

Traders may reassess short-term sentiment around HNGE due to a large insider sale, but the 10b5-1 structure limits inference about new negative fundamentals.

03

What to watch

The filing is indirect (ownership form: indirect) and does not reveal the economic rationale; traders should avoid extrapolating fundamentals from a scheduled sale alone.

Relevance 7/10Novelty 6/10Timing: after-hours/filing timestamp (filed 2026-06-24) for trades dated 2026-06-22 to 2026-06-24

Background

This is an SEC Form 4 insider transaction: Insight Holdings Group, LLC (10% owner) sold Hinge Health shares via open-market trades under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$HNGENeutralMedium confidence
Context

Hinge Health (HNGE) disclosed an SEC Form 4 showing Insight Holdings Group sold 727,793 shares in open-market trades for ~$51.6M.

Expected impact

Near-term impact likely limited; any reaction would be sentiment-driven around insider selling rather than new company fundamentals.

Evidence & confidence

The filing is primary-source and sizable, but it explicitly states a pre-arranged Rule 10b5-1 plan and provides no new operating/regulatory/financial catalyst.

Market effects

Could modestly affect sentiment for digital health/orthopedics-adjacent names if insider selling is interpreted as risk-off, but no sector-wide datapoint is provided.

No direct regional market linkage beyond US-listed HNGE sentiment.

No global macro or cross-border transaction details; impact confined to HNGE positioning.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect liquidity/portfolio rebalancing rather than bearish expectations.

Key entities

  • Hinge Health, Inc.

    US-listed company (HNGE) whose shares were sold in the reported insider transaction.

  • Insight Holdings Group, LLC

    10% owner reporting an indirect open-market sale of HNGE shares under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HNGEHighAI 8/10

Needham raises Hinge Health stock price target on client growth

Needham raised its price target for Hinge Health (NYSE:HNGE) to $135 from $115, citing strong client growth and quarterly performance. The company reported 28% year-over-year client growth, 50% revenue increase, and 154% stock return over six months. Q3 revenue was $235 million, up 52% year-over-year, with EPS of $0.66 beating estimates. Wells Fargo also raised its target to $132, noting strong margins and revenue growth.

$HNGEHighAI 8/10

Hinge Health (HNGE) Q3 2026 Earnings Call Transcript

Hinge Health (HNGE) reported Q3 2026 revenue of $235M, up 52% YoY, with gross margin at 88% and operating income at $77M. The company highlighted growth in its MSK, Migraine, and GI care programs, with strong early results in Migraine care. President Jim Pursley announced his departure at year-end to spend more time with family but will join the board.